Account
Insider Insights
10.02.2022
Reimbursement rate of gliptins revised downwards

In line with legislation published in the Official Journal (Journal Officiel) on 1st February 2022, ...

Read more
Insider Insights
01.02.2022
New restrictions for Prolia

The study showed that 20 - 25% of all prescriptions for the drug were not in line with the drug's au...

Read more
Insider Insights
01.02.2022
Increasing prescribing controls on new medicines

According to data from the Ministry of Health 65.1% of medicines admitted to reimbursement in 2021 w...

Read more
Insider Insights
01.02.2022
Prescribing controls on new medicines

The Ministry of Health reports that 65.1% of medicines admitted to reimbursement in 2021 were subjec...

Read more
Publications
03.12.2021
Pricing and reimbursement policies for digital the

Digital therapeutics (DTx) is a category of digital health, which is defined as products that delive...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.